Topics

"Biocompare LifeMap Sciences Announce Strategic Partnership" Drugs and Medication Database

10:49 EDT 17th September 2019 | BioPortfolio

Here are the most relevant "Biocompare LifeMap Sciences Announce Strategic Partnership" Drugs and Medications that we have found in our database.

More Information about "Biocompare LifeMap Sciences Announce Strategic Partnership" on BioPortfolio

We have published hundreds of Biocompare LifeMap Sciences Announce Strategic Partnership news stories on BioPortfolio along with dozens of Biocompare LifeMap Sciences Announce Strategic Partnership Clinical Trials and PubMed Articles about Biocompare LifeMap Sciences Announce Strategic Partnership for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Biocompare LifeMap Sciences Announce Strategic Partnership Companies in our database. You can also find out about relevant Biocompare LifeMap Sciences Announce Strategic Partnership Drugs and Medications on this site too.

Showing "Biocompare LifeMap Sciences Announce Strategic Partnership" Drugs and Medications 1–25 of 48

Probably Relevant

Mondoxyne nl 100mg [oculus innovative sciences]

Monodoxyne NL 100mg

Mondoxyne [oculus innovative sciences]

Mondoxyne NL 50mg

Deltasone [oculus innovative sciences]

Deltasone 20mg prednisone tablets

Possibly Relevant

Plavix [bristol-myers squibb/sanofi pharmaceuticals partnership]

These highlights do not include all the information needed to use PLAVIX safely and effectively. See full prescribing information for PLAVIX.   PLAVIX (clopidogrel bisulfate) tablets, for oral use Initial U.S. Approval: 1997

Complera access [gilead sciences, inc.]

These highlights do not include all the information needed to use COMPLERA safely and effectively. See full prescribing information for COMPLERA. COMPLERA™ (emtricitabine, rilpivirine, tenofovir disoproxil fumarate) tablets, for oral use GILEAD ACCESS P

Emtriva [gilead sciences, inc.]

These highlights do not include all the information needed to use EMTRIVA safely and effectively. See full prescribing information for EMTRIVA. EMTRIVA (emtricitabine) capsule, for oral use EMTRIVA (emtricitabine) oral solution Initial U.S. Approval: 2003

Isoxsuprine hydrochloride [vedco dba valdar]

Isoxsuprine Hydrochloride Tablets, USP

Isoxsuprine hydrochloride [bi-coastal pharmaceutical corporation]

Isoxsuprine Hydrochloride Tablets, USP

Isoxsuprine hydrochloride [vista pharmaceuticals, inc.]

ISOXSUPRINEHYDROCHLORIDE TABLETS, USP

Isoxsuprine hydrochloride [bi-coastal pharma international limited liability company]

Isoxsuprine Hydrochloride Tablets, USP

Malathion [suven life sciences limited]

Malathion Lotion USP, 0.5%

Paricalcitol [banner life sciences llc.]

These highlights do not include all the information needed to use paricalcitol capsules safely and effectively. See full prescribing information for paricalcitol capsules. PARICALCITOL Capsules Initial U.S. Approval: 1998

Isoxsuprine hydrochloride [eci pharmaceuticals llc]

Isoxsuprine Hydrochloride Tablets, USP

Sovaldi [gilead sciences, inc.]

These highlights do not include all the information needed to use SOVALDI safely and effectively. See full prescribing information for SOVALDI. SOVALDI(sofosbuvir) tablets, for oral use Initial U.S. Approval: 2013

Sovaldi access [gilead sciences, inc.]

These highlights do not include all the information needed to use SOVALDI safely and effectively. See full prescribing information for SOVALDI. GILEAD ACCESS PROGRAM SOVALDI™ (sofosbuvir) tablets, for oral use Initial U.S. Approval: 2013

Raxibacumab [human genome sciences, inc.]

These highlights do not include all the information needed to use RAXIBACUMAB safely and effectively. See full prescribing information for RAXIBACUMAB.RAXIBACUMAB injection, for intravenous use Initial U.S. Approval: 2012

Xepi [cutanea life sciences, inc.]

These highlights do not include all the information needed to use XEPI™ safely and effectively. See full prescribing information for XEPI™. XEPI™ (ozenoxacin) cream, for topical useInitial U.S. Approval: 2017

Terconazole [a-s medication solutions]

TERCONAZOLE VAGINAL CREAM 0.4%7-DAY REGIMENTERCONAZOLE VAGINAL CREAM 0.8%3-DAY REGIMEN

Harvoni [gilead sciences, inc]

These highlights do not include all the information needed to use HARVONI safely and effectively. See full prescribing information for HARVONI. HARVONI (ledipasvir and sofosbuvir) tablets, for oral use Initial U.S. Approval: 2014

Terconazole [actavis pharma, inc]

TERCONAZOLE VAGINAL CREAM 0.4%7-DAY REGIMENTERCONAZOLE VAGINAL CREAM 0.8%3-DAY REGIMEN

Harvoni access [gilead sciences, inc]

These highlights do not include all the information needed to use HARVONI™ safely and effectively. See full prescribing information for HARVONI. HARVONI (ledipasvir and sofosbuvir) tablets, for oral use GILEAD ACCESS PROGRAM Initial U.S. Approval: 2014

Benzonatate [banner life sciences llc.]

BENZONATATE CAPSULES USP, 100 mg and 200 mg

Truvada access [gilead sciences, inc]

These highlights do not include all the information needed to use TRUVADA safely and effectively. See full prescribing information for TRUVADA. TRUVADA™ (emtricitabine and tenofovir disoproxil fumarate) tablets, for oral use GILEAD ACCESS PROGRAM Initia

Potassium acetate [exela pharma sciences, llc.]

Potassium Acetate Injection USP

Truvada [gilead sciences, inc]

These highlights do not include all the information needed to use TRUVADA safely and effectively. See full prescribing information for TRUVADA. TRUVADA(emtricitabine and tenofovir disoproxil fumarate) tablets, for oral use Initial U.S. Approval: 2004



Quick Search